Point-of-Care and Ambulatory Diagnostic Services for Gastric Cancer in the U.S. Valued at USD 459.21 million in 2024, the U.S. gastric cancer diagnostics market is forecasted to expand at a CAGR of 7.4% over the next decade, driven by evolving clinical guidelines, technological innovation, and shifting end-user preferences. The market is highly segmented by product type, application, and end-user, with each segment exhibiting distinct performance characteristics shaped by...
0 Shares
83 Views
0 Reviews